Hap Trading, LLC Chemo Centryx, Inc. Call Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Call Options

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$22.17 - $51.8 $68,727 - $160,580	3,100 Added 10.2%	33,500 $467,000
Q2 2022 Aug 12, 2022	BUY	$15.36 - $27.51 $291,840 - $522,690	19,000 Added 166.67%	30,400 $90,000
Q1 2022 May 12, 2022	SELL	$22.22 - $39.12 $55,550 - $97,800	-2,500 Reduced 17.99%	11,400 $33,000
Q4 2021 Feb 14, 2022	SELL	$18.38 - $40.5 $192,990 - $425,250	-10,500 Reduced 43.03%	13,900 $98,000
Q3 2021 Nov 10, 2021	SELL	$13.18 - $19.83 $334,772 - $503,681	-25,400 Reduced 51.0%	24,400 $134,000
Q2 2021 Aug 11, 2021	BUY	$9.59 - $50.88 $477,582 - $2.53 Million	49,800 New	49,800 $157,000
Q3 2020 Nov 13, 2020	SELL	$46.35 - $61.69 $20.9 Million - $27.8 Million	-450,300 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$38.58 - $65.07 $17.4 Million - $29.3 Million	450,300 New	450,300 $4.64 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.